Jeffrey Marx to Humans
This is a "connection" page, showing publications Jeffrey Marx has written about Humans.
Connection Strength
0.148
-
Ramsey DJ, Lazar DL, Blaha GR, Malott DL, Marx JL. Measuring Patient Loyalty in Ophthalmology: A Nationally Representative Study. Ophthalmology. 2018 07; 125(7):1124-1126.
Score: 0.022
-
Blaha GR, Brooks NO, Mackel CE, Pani A, Stewart AP, Price LL, Barouch FC, Chang J, Marx JL. Changes in flare after intravitreal injection of three different anti-vascular endothelial growth factor medications. Retina. 2015 Mar; 35(3):577-81.
Score: 0.018
-
Marx JL. Ergonomics: back to the future. Ophthalmology. 2012 Feb; 119(2):211-2.
Score: 0.014
-
Blaha GR, Tilton EP, Barouch FC, Marx JL. Randomized trial of anesthetic methods for intravitreal injections. Retina. 2011 Mar; 31(3):535-9.
Score: 0.013
-
Anderson C, Pahk P, Blaha GR, Spindel GP, Alster Y, Rafaeli O, Marx JL. Preferential Hyperacuity Perimetry to detect hydroxychloroquine retinal toxicity. Retina. 2009 Sep; 29(8):1188-92.
Score: 0.012
-
Pahk PJ, Todd DJ, Blaha GR, Soukiasian SH, Landmann DS, Craven DE, Tronic BS, Zabar Y, Marx JL. Intravascular lymphoma masquerading as Vogt-Koyanagi-Harada syndrome. Ocul Immunol Inflamm. 2008 May-Jun; 16(3):123-6.
Score: 0.011
-
Blaha GR, Wertz FD, Marx JL. Profound choroidal hypoperfusion after combined photodynamic therapy and intravitreal triamcinolone acetonide. Ophthalmic Surg Lasers Imaging. 2008 Jan-Feb; 39(1):6-11.
Score: 0.011
-
Dhimitri KC, McGwin G, McNeal SF, Lee P, Morse PA, Patterson M, Wertz FD, Marx JL. Symptoms of musculoskeletal disorders in ophthalmologists. Am J Ophthalmol. 2005 Jan; 139(1):179-81.
Score: 0.009
-
Yepremyan M, Wertz FD, Tivnan T, Eversman L, Marx JL. Early treatment of cystoid macular edema secondary to branch retinal vein occlusion with intravitreal triamcinolone acetonide. Ophthalmic Surg Lasers Imaging. 2005 Jan-Feb; 36(1):30-6.
Score: 0.009
-
Marx JL, Hreib K, Choi IS, Tivnan T, Wertz FD. Percutaneous carotid artery angioplasty and stenting for ocular ischemic syndrome. Ophthalmology. 2004 Dec; 111(12):2284-91.
Score: 0.009
-
Sethi K, Levine ES, Roh S, Marx JL, Ramsey DJ. Modeling the impact of COVID-19 on Retina Clinic Performance. BMC Ophthalmol. 2021 May 10; 21(1):206.
Score: 0.007
-
Moshfeghi DM, Hariprasad SM, Marx JL, Thompson D, Soo Y, Gibson A, Saroj N, Vitti R, Heier JS. Effect of Fluid Status at Week 12 on Visual and Anatomic Outcomes at Week 52 in the VIEW 1 and 2 Trials. Ophthalmic Surg Lasers Imaging Retina. 2016 Mar; 47(3):238-44.
Score: 0.005
-
Yoon SJ, Rhee DY, Marx JL, Blaha GR, Rogers AH, Baumal CR, Reichel E, Duker JS. Anatomic and visual outcomes of noninfectious endophthalmitis after intravitreal triamcinolone. Am J Ophthalmol. 2009 Jun; 147(6):1031-6.
Score: 0.003
-
Boyer DS, Beer PM, Joffe L, Koester JM, Marx JL, Weisberger A, Yoser SL. Effect of adjunctive diclofenac with verteporfin therapy to treat choroidal neovascularization due to age-related macular degeneration: phase II study. Retina. 2007 Jul-Aug; 27(6):693-700.
Score: 0.003
-
Flattem NL, Marx JL, Gawoski J. Fluorescein interference with homocysteine testing. Arch Ophthalmol. 2005 Jan; 123(1):114-6.
Score: 0.002
-
Brown BA, Marx JL, Ward TP, Hollifield RD, Dick JS, Brozetti JJ, Howard RS, Thach AB. Homocysteine: a risk factor for retinal venous occlusive disease. Ophthalmology. 2002 Feb; 109(2):287-90.
Score: 0.002